Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › VA › LEESBURG › INOVA HEALTH CARE SERVICES

INOVA HEALTH CARE SERVICES

NPI: 1376564302 · LEESBURG, VA 20176 · Substance Use Disorder Rehabilitation Clinic/Center · NPI assigned 07/23/2006

$46.97M
Total Medicaid Paid
957,277
Total Claims
752,972
Beneficiaries
300
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTALENTO, RICARDO (CORPORATE CHIEF FINANCIAL OFFICER)
NPI Enumeration Date07/23/2006

Related Entities

Other providers sharing the same authorized official: TALENTO, RICARDO

ProviderCityStateTotal Paid
INOVA HEALTH CARE SERVICES FALLS CHURCH VA $176.68M
INOVA HEALTH CARE SERVICES ALEXANDRIA VA $69.02M
INOVA HEALTH CARE SERVICES ALEXANDRIA VA $39.33M
INOVA HEALTH CARE SERVICES FAIRFAX VA $33.53M
INOVA HEALTH CARE SERVICES SPRINGFIELD VA $8.88M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 90,989 $2.96M
2019 110,698 $4.27M
2020 98,102 $4.14M
2021 126,663 $5.48M
2022 162,777 $8.07M
2023 191,112 $10.80M
2024 176,936 $11.24M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 47,859 41,792 $9.30M
99284 Emergency department visit for the evaluation and management, high severity 34,150 29,401 $7.40M
96361 Intravenous infusion, hydration; each additional hour 20,171 15,719 $6.24M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 14,722 13,093 $3.33M
G0378 Hospital observation service, per hour 7,617 6,447 $2.28M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 14,490 4,439 $1.45M
70450 Computed tomography, head or brain; without contrast material 8,155 7,213 $1.44M
97530 Therapeutic activities, direct patient contact, each 15 minutes 28,753 8,736 $1.23M
74177 Computed tomography, abdomen and pelvis; with contrast material 6,794 6,167 $1.14M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 6,446 5,837 $860K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,103 4,592 $813K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,805 1,673 $603K
71275 Computed tomographic angiography, chest, with contrast material 2,542 2,366 $575K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 1,740 1,625 $572K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 5,643 4,422 $500K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 12,195 3,865 $488K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6,610 6,263 $479K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3,515 2,439 $475K
59025 Fetal non-stress test 2,033 1,146 $415K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2,372 1,469 $399K
76705 Ultrasound, abdominal, real time with image documentation; limited 4,082 3,738 $361K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,087 5,214 $335K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 3,390 2,974 $322K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 5,771 4,640 $307K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 8,642 2,814 $303K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,959 1,761 $294K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 3,046 2,829 $287K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 2,393 2,256 $269K
97161 2,124 1,920 $214K
76830 Ultrasound, transvaginal 2,322 2,142 $212K
0202U Oncology (prostate), multianalyte, gene expression profiling 1,513 1,463 $188K
80053 Comprehensive metabolic panel 44,124 34,585 $181K
87400 13,518 8,507 $156K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1,611 1,535 $154K
92526 3,729 1,419 $150K
93976 2,015 1,848 $141K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 2,046 1,516 $131K
76801 2,390 2,003 $116K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 242 228 $99K
97162 627 591 $99K
76770 714 690 $96K
G0379 Direct admission of patient for hospital observation care 429 376 $93K
93971 1,012 933 $90K
70496 378 360 $88K
71046 Radiologic examination, chest; 2 views 8,759 7,905 $85K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 370 208 $82K
97165 941 862 $81K
76819 Fetal biophysical profile; without non-stress testing 1,143 829 $76K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 6,191 5,078 $72K
93970 572 539 $70K
70551 Magnetic resonance imaging, brain; without contrast material 503 464 $68K
87420 3,863 3,509 $63K
76700 Ultrasound, abdominal, real time with image documentation; complete 379 360 $60K
12001 284 278 $56K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 11,428 10,830 $55K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 2,367 1,932 $54K
92610 426 391 $47K
87040 7,274 4,647 $43K
72125 Computed tomography, cervical spine; without contrast material 2,592 2,332 $42K
87505 491 457 $40K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 43 43 $37K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,022 1,779 $36K
92523 291 267 $36K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,648 2,448 $34K
J3490 Unclassified drugs 15,339 7,525 $34K
12011 161 156 $34K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1,930 622 $33K
72131 651 615 $31K
83880 4,207 3,618 $30K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 47,590 36,971 $30K
71045 Radiologic examination, chest; single view 14,170 12,352 $29K
74018 1,979 1,780 $28K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 23,277 17,929 $28K
70486 596 563 $27K
71250 463 433 $26K
80048 Basic metabolic panel (calcium, ionized) 7,484 5,801 $26K
71260 Computed tomography, thorax, diagnostic; with contrast material 165 161 $25K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,668 2,467 $24K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,913 1,230 $22K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 20,839 17,766 $22K
73564 1,662 1,365 $21K
85379 4,693 4,234 $21K
87081 16,394 14,887 $20K
70498 428 404 $20K
36415 Collection of venous blood by venipuncture 12,071 9,127 $19K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 71 66 $19K
84484 16,149 12,198 $19K
73630 1,968 1,717 $17K
76536 142 137 $16K
85027 6,988 5,444 $16K
73610 1,931 1,729 $16K
76820 627 388 $16K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 829 806 $15K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 85 81 $15K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 5,351 4,684 $14K
77063 Screening digital breast tomosynthesis, bilateral 264 251 $14K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 635 605 $13K
90715 593 572 $13K
87086 Culture, bacterial; quantitative colony count, urine 12,127 10,879 $13K
84443 Thyroid stimulating hormone (TSH) 5,913 5,297 $12K
73030 1,409 1,237 $12K
96376 6,444 3,775 $12K
76870 164 159 $12K
73080 620 564 $11K
70491 62 59 $11K
J8540 Dexamethasone, oral, 0.25 mg 801 686 $9K
87430 15,755 14,707 $9K
80143 2,403 2,077 $9K
73560 644 522 $8K
86780 1,347 1,285 $8K
73130 1,128 955 $8K
96375 Therapeutic injection; each additional sequential IV push 15,334 11,993 $7K
73590 641 566 $7K
83036 Hemoglobin; glycosylated (A1C) 2,551 2,322 $6K
73110 798 734 $6K
82728 683 641 $6K
77067 Screening mammography, bilateral, including computer-aided detection 398 375 $6K
86140 3,796 3,333 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 10,939 9,778 $6K
80061 Lipid panel 1,783 1,621 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 14 12 $6K
93798 65 12 $6K
97163 35 33 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,991 5,177 $6K
81003 8,576 7,624 $6K
84702 3,094 2,516 $5K
74019 1,365 1,274 $5K
76642 57 39 $5K
81001 20,155 17,744 $5K
74183 13 13 $5K
82950 1,076 1,043 $5K
J7030 Infusion, normal saline solution , 1000 cc 5,244 3,919 $5K
73090 360 311 $5K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 256 226 $5K
86900 4,840 3,997 $5K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 20 19 $5K
83735 13,285 10,075 $5K
80179 2,310 2,016 $5K
83690 13,784 11,724 $5K
82248 1,826 1,184 $4K
96367 472 411 $4K
97116 281 84 $4K
83605 3,722 3,068 $4K
86762 807 788 $4K
85610 8,966 7,239 $4K
86850 4,306 3,859 $4K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 471 317 $4K
84703 10,663 9,255 $4K
74174 15 14 $4K
S0028 Injection, famotidine, 20 mg 2,761 2,342 $3K
29125 14 12 $3K
97113 78 24 $3K
72141 18 18 $3K
84439 520 482 $3K
12002 14 14 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 952 849 $3K
86803 853 825 $3K
85014 1,235 1,049 $3K
82247 631 361 $3K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 9,428 8,345 $2K
93017 55 54 $2K
83550 610 575 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 14,040 11,331 $2K
85652 4,531 4,067 $2K
87077 3,938 3,410 $2K
86901 4,835 3,996 $2K
72128 77 74 $2K
87340 1,109 1,069 $2K
84100 4,126 3,198 $2K
73140 308 289 $2K
S0020 Injection, bupivicaine hydrochloride, 30 ml 344 297 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 3,657 3,266 $2K
83540 635 598 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,473 919 $2K
85730 7,603 6,366 $2K
81025 4,054 3,674 $2K
82105 77 76 $2K
82550 2,219 1,856 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 121 117 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 13 13 $1K
82570 797 684 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 10,954 9,140 $1K
87186 3,203 2,570 $1K
G0008 Administration of influenza virus vaccine 68 66 $997.81
73502 61 56 $937.02
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 760 665 $870.78
85018 562 468 $858.87
72100 39 39 $840.94
84156 668 557 $723.86
J2270 Injection, morphine sulfate, up to 10 mg 5,550 4,155 $722.51
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 49 46 $653.05
J7120 Ringers lactate infusion, up to 1000 cc 1,459 1,163 $635.14
87205 1,444 1,192 $632.38
82607 73 71 $627.20
87070 1,450 1,205 $621.73
72110 14 12 $602.39
J0696 Injection, ceftriaxone sodium, per 250 mg 3,847 2,964 $509.61
J3010 Injection, fentanyl citrate, 0.1 mg 3,424 2,704 $509.14
88304 221 191 $467.95
84550 780 630 $447.11
J3535 Drug administered through a metered dose inhaler 927 822 $442.40
87210 964 891 $427.84
86141 2,097 1,952 $377.24
J2060 Injection, lorazepam, 2 mg 895 674 $327.69
83615 689 553 $317.36
36416 416 272 $317.23
87563 180 172 $303.34
J1650 Injection, enoxaparin sodium, 10 mg 2,057 1,031 $295.23
96110 Developmental screening, with scoring and documentation, per standardized instrument 12 12 $282.45
97535 Self-care/home management training, each 15 minutes 15 12 $274.90
J7050 Infusion, normal saline solution, 250 cc 1,523 701 $271.81
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 387 351 $264.40
J1170 Injection, hydromorphone, up to 4 mg 2,471 1,602 $253.77
87486 12 12 $247.34
85049 102 101 $238.19
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 2,268 1,736 $231.66
C1769 Guide wire 517 465 $225.20
J0690 Injection, cefazolin sodium, 500 mg 1,845 1,256 $210.43
82565 180 150 $190.92
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 14 13 $188.30
90686 15 14 $184.59
82951 13 13 $177.46
83655 16 16 $172.72
84450 193 154 $171.88
87581 12 12 $154.86
73501 13 12 $154.68
86038 15 12 $151.27
86308 506 487 $149.81
72170 64 62 $146.49
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,653 1,411 $136.32
73552 47 43 $134.82
88342 57 52 $134.08
J3475 Injection, magnesium sulfate, per 500 mg 1,006 769 $132.68
99152 180 164 $114.13
80076 13 12 $103.08
86665 186 107 $101.08
84145 679 624 $100.87
82746 13 13 $99.64
84460 199 160 $99.29
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 994 891 $98.28
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,061 913 $95.94
86664 99 94 $91.17
A9575 Injection, gadoterate meglumine, 0.1 ml 854 792 $88.49
87328 182 177 $83.38
J2550 Injection, promethazine hcl, up to 50 mg 803 627 $82.83
86317 12 12 $72.49
J7042 5% dextrose/normal saline (500 ml = 1 unit) 221 157 $69.87
J2704 Injection, propofol, 10 mg 2,081 1,694 $55.42
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 12 12 $48.64
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 276 245 $48.45
84112 74 67 $42.03
J7510 Prednisolone oral, per 5 mg 188 169 $40.17
94664 203 173 $38.30
A9585 Injection, gadobutrol, 0.1 ml 230 205 $21.98
85007 153 141 $21.24
87425 86 83 $19.62
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 191 140 $17.52
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 204 179 $14.51
J2765 Injection, metoclopramide hcl, up to 10 mg 582 497 $14.18
82805 89 79 $14.12
87329 50 50 $10.12
J7060 5% dextrose/water (500 ml = 1 unit) 21 12 $7.04
86618 37 36 $6.16
J1815 Injection, insulin, per 5 units 88 25 $5.78
87075 17 12 $5.23
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 492 329 $4.24
J0780 Injection, prochlorperazine, up to 10 mg 305 260 $2.85
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 96 90 $1.25
C9113 Injection, pantoprazole sodium, per vial 455 246 $0.00
J1644 Injection, heparin sodium, per 1000 units 306 162 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 273 249 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 16 12 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 220 199 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 254 166 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 127 81 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 1,489 1,060 $0.00
J1756 Injection, iron sucrose, 1 mg 24 13 $0.00
J3370 Injection, vancomycin hcl, 500 mg 76 54 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 102 67 $0.00
S5010 5% dextrose and 0.45% normal saline, 1000 ml 16 13 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 57 55 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 21 20 $0.00
J1171 Injection, hydromorphone, 0.1 mg 104 65 $0.00
J7699 Noc drugs, inhalation solution administered through dme 31 28 $0.00
J3480 Injection, potassium chloride, per 2 meq 133 96 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 365 123 $0.00
J8597 Antiemetic drug, oral, not otherwise specified 123 104 $0.00
J3360 Injection, diazepam, up to 5 mg 115 101 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 84 54 $0.00
J3411 Injection, thiamine hcl, 100 mg 67 52 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 24 18 $0.00
99292 55 52 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 39 39 $0.00
73060 25 25 $0.00
94760 14 12 $0.00
J1940 Injection, furosemide, up to 20 mg 64 39 $0.00
J2785 Injection, regadenoson, 0.1 mg 12 12 $0.00
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 33 33 $0.00
80047 47 43 $0.00
87493 14 13 $0.00